Drug Profile


Alternative Names: Vanorm; WIN 42362; WY 42362

Latest Information Update: 22 Nov 1999

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Wyeth
  • Class Class Ia antiarrhythmics; Class Ib antiarrhythmics; Class Ic antiarrhythmics; Phenylurea compounds; Small molecules
  • Mechanism of Action Sodium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Arrhythmias

Most Recent Events

  • 22 Nov 1999 No-Development-Reported for Arrhythmias in USA (IV)
  • 22 Nov 1999 No-Development-Reported for Arrhythmias in USA (PO)
  • 10 Aug 1995 A pharmacokinetic study has been added
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top